Provayblue

methylene blue

Solution (intravenous) · NDA 204630

Last listed protection ends

January 8, 2027

The FDA lists 1 exclusivity for Provayblue, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities